Burning Rock Biotech Ltd. engages in the investment of medical fields. The company is headquartered in Guangzhou, Guangdong and currently employs 674 full-time employees. The company went IPO on 2020-06-12. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Follow-Up Questions
What is the price performance of BNR stock?
The current price of BNR is $8.41, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Burning Rock Biotech Ltd?
Burning Rock Biotech Ltd belongs to Biotechnology industry and the sector is Health Care
What is Burning Rock Biotech Ltd market cap?
Burning Rock Biotech Ltd's current market cap is $86.2M
Is Burning Rock Biotech Ltd a buy, sell, or hold?
According to wall street analysts, 2 analysts have made analyst ratings for Burning Rock Biotech Ltd, including 1 strong buy, 3 buy, 1 hold, 0 sell, and 1 strong sell
